2van Domburg RT, Lemos PA,Takkenberg JM, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J,2005,26:675-681. 被引量：1
4Cook S, Togni M, Walpoth N, et al. Percutaneous Coronary Interventions in Europe 1992-2003. Eurolnterv,2006,1:374-379. 被引量：1
5Jensen LO, Maeng MI, Thayssen P, et al. Impact of drug eluting stents on target vessel revascularization. A report from the western Denmark heart registry from 2000 to 2004. Eurolnterv, 2006,1:391-395. 被引量：1
6Nagle PC, Smith AW. Review of recent US cost estimates of revascularization. Am J Manag Care, 2004,10:S370-S376. 被引量：1
2Gronstein BN;Naime D;Ostad E.The antiinflammtory mechanism of methotrexate:increased adenosine release at infl amed sites diminishes leukocyte accumulation in an in vivo model of inflammation[J]Journal of Clinical Investigation,1993(06):2675-2682. 被引量：1
3Schwartz RS;Huber KC;Murphy JG.Restenosis and the proportional neointimal response to coronary artery injury:Results in a porcine model[J]Journal of the American College of Cardiology,1992(02):267-274. 被引量：1
5Takallapalli Ramesh;Kumar Rao;P.Rani Usha;M.U.R.Naidu.Bioequivalence and tolerability study of two brands of clopidogrel tablets,using inhibition of platelet aggregation and pharmacodynamic measures[J]Current Therapeutic Research,2003(09):685-696. 被引量：1
